Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Reduction of vascular leakage by imatinib is associated with preserved microcirculatory perfusion and reduced renal injury markers in a rat model of cardiopulmonary bypass.

British journal of anaesthesia·2018
Same author

The minor histocompatibility antigen 1 (HMHA1)/ArhGAP45 is a RacGAP and a novel regulator of endothelial integrity.

Vascular pharmacology·2017
Same author

A CDC42-centered signaling unit is a dominant positive regulator of endothelial integrity.

Scientific reports·2017
Same author

Endothelial hyperpermeability after cardiac surgery with cardiopulmonary bypass as assessed using an in vitro bioassay for endothelial barrier function.

British journal of anaesthesia·2016
Same author

Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.

The European respiratory journal·2010
Same author

Possible role of imatinib in clinical pulmonary veno-occlusive disease.

The European respiratory journal·2008

関連する実験動画

Updated: Jul 11, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

シムバスタチンは,内皮の障壁機能の障害を改善します.

G P van Nieuw Amerongen1, M A Vermeer, P Nègre-Aminou

  • 1Gaubius Laboratory TNO-PG, Leiden, The Netherlands.

Circulation
|January 11, 2000
PubMed
まとめ

シムバスタチンは,内皮の障壁機能を改善し,血管の漏れを軽減し,脂質低下を超えて,潜在的に心血管疾患の減少に貢献します. この研究は,シムバスタチンを実証しています.

科学分野:

  • 心血管科学の研究について
  • 内皮細胞生物学 エンドセル生物学
  • 薬理学 薬理学とは

背景:

  • スタチン (3-ヒドロキシ-3-メチルグルタリル共酵素A還元酵素阻害剤) は,急性冠動脈イベントを軽減する.
  • スタチンの効果は,脂質減少を超えて,他のメカニズムを示唆しています.
  • 内皮機能の改善は,スタチンの心臓保護効果に役割を果たす可能性があります.

研究 の 目的:

  • 内皮の障壁機能に対するシムバスタチンの効果を調査する.
  • シムバスタチンが内皮の障壁機能不全を緩和するかどうかを in vitro および in vivo で判定する.
  • 脂質低下から独立したシンバスタチンの作用のメカニズムを探求する.

主な方法:

  • 人間の静脈と大動脈内皮細胞は,シンバスタチンで治療されました.
  • 内皮壁の機能はペロキシダースとLDL経路の測定によって評価されました.
  • ワタナベの遺伝性高脂症ウサギはシンバスタチンで治療され,血管漏れはエヴァンスブルー染料排除テストを使用して評価されました.

主要な成果:

  • シムバスタチン (5マイクロモル/L) は,トロンビン誘発の内皮壁機能不全をインビトロで55%大幅に減少させた.

さらに関連する動画

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

関連する実験動画

Last Updated: Jul 11, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

  • シムバスタチンの投与量と時間により,ストレス繊維形成とRhoA膜結合が減少した.
  • ウサギでは,シンバスタチン治療により,動脈硬化性病変のサイズを変えることなく,大動脈血管漏れを軽減しました.
  • 結論:

    • シムバスタチンは,高濃度でインビトロおよびインビボにおいて,内皮のバリア機能を改善します.
    • これらの発見は,非脂質低下メカニズムを通じた急性冠動脈イベントに対するシムバスタチンの有益な効果を支持する.
    • シムバスタチンの内皮壁の完全性への影響は,新しい治療的洞察を提供します.